 | Up a level |
Perilongo, Giorgio; Maibach, Rudolf; Shafford, Elisabeth; Brugieres, Laurence; Brock, Penelope; Morland, Bruce; de Camargo, Beatriz; Zsiros, Jozsef; Roebuck, Derek; Zimmermann, Arthur; Aronson, Daniel; Childs, Margaret; Widing, Eva; Laithier, Veronique; Plaschkes, Jack; Pritchard, Jon; Scopinaro, Marcello; MacKinlay, Gordon; Czauderna, Piotr (2009). Cisplatin versus cisplatin plus doxorubicin for standard-risk hepatoblastoma. New England journal of medicine NEJM, 361(17), pp. 1662-70. Waltham, Mass.: Massachusetts Medical Society MMS 10.1056/NEJMoa0810613
